Haiting Wang, M.D., Ph.D.

Postdoctoral Fellow

Systemic Autoimmunity Branch

Headshot of a young woman with dark hair

Contact Information

Summary

Dr. Haiting Wang received her M.D. from Zhengzhou University in China and completed her residency in internal medicine and fellowship in rheumatology at Shanghai Jiao Tong University School of Medicine. She subsequently worked as a physician in the Department of Rheumatology at Renji Hospital, affiliated with the Shanghai Jiao Tong University School of Medicine. In 2023, Dr. Wang earned her Ph.D. in Immunology. Her clinical and research interests focus on systemic autoimmune diseases, particularly systemic lupus erythematosus (SLE). In July 2024, she joined the NIH as a postdoctoral fellow, where she studies myeloid cell biology in lupus using both mouse models and patient samples.

Research Statement

Dr. Wang’s research aims to understand how myeloid cell development, differentiation, function, and metabolic regulation contribute to autoimmune inflammation and organ damage in SLE. She is particularly interested in the immune mechanisms underlying SLE-associated complications, including lupus myocarditis, to facilitate the development of novel therapeutic strategies.

Scientific Publications

Dysbiosis-induced expansion of AXL-positive inflammatory type 3 dendritic cells triggers preclinical autoimmunity.

Cvijetic G, Ottaviani V, Conway IO, Jabari E, Mitrovic M, Wang H, Rodrigues PF, du Halgouet A, Zhao S, Wang HC, Chandroth AP, Palmer RJ Jr, Ansaldo E, Doyle AD, Martin D, Szabo R, Corsino C, Pala F, Fernandes MR, Bouladoux N, Young HA, Zheng Y, Liu Z, Ginhoux F, Dang EV, Darnell S, Liechti G, Lionakis MS, Ivanek R, Notarangelo LD, Belkaid Y, Chen W, Dzutsev A, Trinchieri G, Tussiwand R
Nat Immunol.
2026 Jul 21;
doi: 10.1038/s41590-026-02599-z
PMID: 42481649

Rituximab as the first-line treatment in newly diagnosed systemic lupus erythematosus.

Wang H, Zhao L, Yang S, Ding H, Wu W, Yu L, Jin J, Shen N, Fu Q, Ye S
Front Immunol.
2025;
16().
doi: 10.3389/fimmu.2025.1599473
PMID: 40621471

Pyruvate Kinase M2 Nuclear Translocation Regulate Ferroptosis-Associated Acute Lung Injury in Cytokine Storm.

Wang H, Fan C, Chen X, Zhou W, Guo L, Zhao F, Ye S, He S, Chen Y
Inflammation.
2024 Oct;
47(5).
doi: 10.1007/s10753-024-02000-x
PMID: 38483700

Dendritic cell type 3 arises from Ly6C(+) monocyte-dendritic cell progenitors.

Liu Z, Wang H, Li Z, Dress RJ, Zhu Y, Zhang S, De Feo D, Kong WT, Cai P, Shin A, Piot C, Yu J, Gu Y, Zhang M, Gao C, Chen L, Wang H, Vétillard M, Guermonprez P, Kwok I, Ng LG, Chakarov S, Schlitzer A, Becher B, Dutertre CA, Su B, Ginhoux F
Immunity.
2023 Aug 8;
56(8).
doi: 10.1016/j.immuni.2023.07.001
PMID: 37506694

Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study.

Wang H, Zhou Y, Yu L, Wu W, Zhao L, Geng S, Sun F, Zhang D, Shen N, Chen Y, Ye S
Lupus Sci Med.
2022 Aug;
9(1).
doi: 10.1136/lupus-2022-000725
PMID: 36041813

Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.

Wang H, Li T, Chen S, Gu Y, Ye S
Arthritis Rheumatol.
2015 Dec;
67(12).
doi: 10.1002/art.39296
PMID: 26245802

Education

Zhengzhou University School of Medicine, China 
M.D. (2011) 

Shanghai JiaoTong University School of Medicine, China 
Masters in Internal Medicine (2014) 

Shanghai JiaoTong University School of Medicine, China 
Ph.D. in Immunology (2023)

Experience

Internal Medicine Resident 
Renji Hospital, Shanghai, China (2014-2016) 

Rheumatology Fellowship 
Renji Hospital, Shanghai, China (2019-2023) 

Postdoctoral Fellow 
Immune Regulation Unit, NIDCR (2024-2026)

Last Updated: